Martin R. Jefson

Amministratore Delegato presso Pinteon Therapeutics, Inc.

Health Technology

Profilo

Martin R.
Jefson is currently the Chief Executive Officer at Pinteon Therapeutics, Inc. He was previously the Chief Scientific Officer at Rodin Therapeutics, Inc. and Ataxion, Inc.

Posizioni attive di Martin R. Jefson

Società	Posizione	Inizio
Pinteon Therapeutics, Inc. Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA.	Amministratore Delegato	-

Tutte le posizioni attive di Martin R. Jefson

Precedenti posizioni note di Martin R. Jefson

Società	Posizione	Fine
Rodin Therapeutics, Inc. Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.	Direttore Tecnico/Scientifico/R&S	-
Ataxion, Inc. Ataxion, Inc. BiotechnologyHealth Technology Ataxion, Inc. develops novel therapies for rare, debilitating, and underserved neurologic diseases. It focuses on orphan genetic disorders termed hereditary ataxias. It was founded by Josh Resnick and David Grayzel in April 2013 and is headquartered in Cambridge, MA.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Martin R. Jefson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Martin R. Jefson

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
Ataxion, Inc. Ataxion, Inc. BiotechnologyHealth Technology Ataxion, Inc. develops novel therapies for rare, debilitating, and underserved neurologic diseases. It focuses on orphan genetic disorders termed hereditary ataxias. It was founded by Josh Resnick and David Grayzel in April 2013 and is headquartered in Cambridge, MA.	Health Technology
Rodin Therapeutics, Inc. Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.	Health Technology
Pinteon Therapeutics, Inc. Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA.	Health Technology

Vedi le connessioni aziendali

Borsa valori
Insiders
Martin R. Jefson